Top compounds associated with response to LYPD1


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.087 0.01
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.097 0.01
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.095 0.01
mRNA vincristine CTRPv2 pan-cancer AAC -0.085 0.01
mRNA Bortezomib gCSI pan-cancer AAC -0.19 0.01
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.091 0.01
mRNA Rapamycin gCSI pan-cancer AAC -0.17 0.01
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA FK866 GDSC1000 pan-cancer AAC -0.081 0.01
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.085 0.02
Download CSV